Centessa Pharmaceuticals plc (CNTA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $61.30M | -84.0% |
| 2024 | $383.22M | +199.3% |
| 2023 | $128.03M | -67.5% |
| 2022 | $393.64M | -33.9% |
| 2021 | $595.08M | +8134.1% |
| 2020 | $7.23M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $61.30M | -84.0% |
| 2024 | $383.22M | +199.3% |
| 2023 | $128.03M | -67.5% |
| 2022 | $393.64M | -33.9% |
| 2021 | $595.08M | +8134.1% |
| 2020 | $7.23M | — |